Vertex Pharmaceuticals Incorporated
Registered Principal Details
Business Or Interest:
Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines so people with serious diseases can lead better lives.
Lobbying Interests:
Medicaid and Health Issues.
CEO Name:
Jeffrey Leiden
Senior Director, State Government Affairs
Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines so people with serious diseases can lead better lives.
Lobbying Interests:
Medicaid and Health Issues.
CEO Name:
Jeffrey Leiden
Senior Director, State Government Affairs
Contact
AP
Abigail Parta
50 Northern Avenue
Boston, MA 20001
(617) 961-7770
Abby_Parta@vrtx.com
http://www.vrtx.com
50 Northern Avenue
Boston, MA 20001
(617) 961-7770
Abby_Parta@vrtx.com
http://www.vrtx.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Health Services: Departmentwide
Health Services: Departmentwide
Notification Date
3/11/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/11/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Biennial budget bill treatment of matter relating to
Health Services: Medicaid Services
Health Services: Medicaid Services
Notification Date
3/11/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/11/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Biennial budget bill treatment of matter relating to
Insurance: Departmentwide
Insurance: Departmentwide
Notification Date
3/11/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/11/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Issues related to Governor Evers' Public Health Emergency Declaration and COVID-19 Response
Issues related to Governor Evers' Public Health Emergency Declaration and COVID-19 Response
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/24/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/24/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Issues related to Governor Evers' Public Health Emergency Declaration and COVID-19 Response
Issues related to Governor Evers' Public Health Emergency Declaration and COVID-19 Response
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/23/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/23/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to treatment of cyclic fibrosis.
Development, drafting or introduction of a proposal relating to treatment of cyclic fibrosis.
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/28/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/28/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to work requirements for Medicaid coverage.
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to work requirements for Medicaid coverage.
Development, drafting or introduction of a proposal relating to work requirements for Medicaid coverage.
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/28/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/28/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to regulation of pharmaceutical manufacturers.
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to regulation of pharmaceutical manufacturers.
Development, drafting or introduction of a proposal relating to regulation of pharmaceutical manufacturers.
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/28/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/28/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Medicaid drug coverage process and procedure.
Medicaid drug coverage process and procedure.
Action Intended To Affect
Rule (by a state agency)
Notification Date
12/21/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Rule (by a state agency)
Notification Date
12/21/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2019 January - June $24,000.00 |
2019 July - December $24,000.00 |
2020 January - June $24,000.00 |
2020 July - December $0.00 |
Total $72,000.00 |
| Total Hours Communicating | 2019 January - June 3.00 |
2019 July - December 3.50 |
2020 January - June 0.00 |
2020 July - December 0.00 |
Total 6.50 |
| Total Hours Other | 2019 January - June 20.00 |
2019 July - December 9.00 |
2020 January - June 14.00 |
2020 July - December 3.00 |
Total 46.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
No legislative bills/resolutions found.
Budget Bill Subjects
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June 20% |
2019 July - December |
2020 January - June |
2020 July - December |
Total 10% |
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to work requirements for Medicaid coverage.
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June 20% |
2019 July - December 60% |
2020 January - June 40% |
2020 July - December |
Total 34% |
Development, drafting or introduction of a proposal relating to regulation of pharmaceutical manufacturers.
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June 20% |
2019 July - December 10% |
2020 January - June |
2020 July - December |
Total 11% |
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June 40% |
2019 July - December 30% |
2020 January - June 30% |
2020 July - December |
Total 33% |
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June |
2019 July - December |
2020 January - June 30% |
2020 July - December |
Total 8% |
Minor Efforts
No minor efforts found.
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication